 |
Medicare Part D FAQ
What is the Medicare Drug Benefit or Part D?
The Medicare Drug Benefit, known as Medicare Part D, is prescription drug
coverage for all Medicare eligible persons. This benefit is for seniors over 65
years old, whether community based or institutionalized, and includes
individuals younger than 65 if they are Medicare eligible due to a disability.
Medicare Part D is mandated for individuals who fall into the category of “Full
Benefit Dual Eligible”, defined as people who qualify to receive benefits under
both Medicare and Medicaid. The plan is optional for non-dual eligibles.
Medicare Part D began January 1, 2006.
The purpose of this benefit is twofold: to provide a prescription drug coverage
program for all Medicare Beneficiaries and to shift the cost responsibility
from states to a federal program which will operate through privatized
Prescription Drug Plans (PDPs) authorized by CMS to administer the benefit.
What elements of the legislation directly impact long-term
care facilities?
-
Benefits are provided through two different types of plans: a Prescription Drug
Plan (PDP), which is a stand-alone drug benefit, or through a Medicare
Advantage Prescription Drug plan (MA-PD), which incorporates both a health care
and drug benefit.
-
Eligible beneficiaries receive prescription drug coverage through Medicare Part
D privatized Prescription Drug Plans (PDPs) authorized by CMS.
-
Enrollment into Medicare Part D is MANDATORY for dual-eligible residents
(Medicare AND Medicaid beneficiaries). CMS auto-enrolls eligibles into
PDPs as they become eligible.
-
Medicare Part D participation is VOLUNTARY for Private Pay residents who are
Medicare eligible (Part A and/or Part B) but NOT eligible for Medicaid.
Voluntary enrollment for these non-dual beneficiaries ran from November 15,
2005 to May 15, 2006. If they did not enroll during this period, effective June
2006, a 1% monthly penalty is added to their monthly premium, once they
enroll in a PDP. Non-duals in long-term care facilities qualify for the Special
Enrollment Period, which allows them an opportunity to enroll into a PDP/change
PDPs once per month beyond the open enrollment period.
-
Low-income beneficiaries receive government assistance in paying for their
drugs, premiums and cost sharing. This assistance applies, in varying degrees,
to residents with income under 150 percent of the federal poverty level.
-
Private Pay residents who are NOT Medicare or Medicaid eligible, or are
eligible but not signed up, maintain responsibility for prescription drug
coverage through self-payment or utilization of private insurance plans.
-
Residents who are NOT Medicare eligible, but are Medicaid eligible may have
prescription drug coverage through the state Medicaid program.
-
Residents in Medicare A stays have no changes in prescription drug coverage.
The facility is still responsible for payment of their prescription drugs under
Medicare Part A PPS.
-
Each PDP has its own formulary, which is a preferred drug list covered by a
particular health plan, meaning the potential exists for multiple formularies
and procedures within the long-term care facility.
-
Residents need to transition from current medications to medications covered by
the PDP formularies.
-
According to the legislation, Insulin, Insulin syringes, gauze, alcohol
pads are covered. All other injectables, including infusion therapy, may
require prior authorization or formulary appeal. Devices for medication
administration are not covered (e.g. spacers for inhalation products, flushing
supplies (heparin, saline)).
-
The legislation contains language specific to formulary exclusions (non-covered
items), which is an issue for beneficiaries who need coverage on items such
as*:
-
Benzodiazepines
-
Over-the-counter medications
-
Drugs to cause or treat weight loss
-
Barbiturates
-
Cough & cold products
-
Prescription vitamins
* To date, the majority of states have tentatively agreed to
provide coverage for some or all of the excluded classes of drugs. Coverage
will vary from state to state.
What does CMS require of PDPs regarding drug formularies?
CMS set minimum criteria of two drugs per therapeutic category/class and gave
little additional guidance to PDPs in establishing their formularies. CMS did
indicate that all or substantially all, drugs must be covered in six key
therapeutic classes, to be sure PDPs do not discriminate against certain
disease states. Those classes include antidepressants, antipsychotics,
anticonvulsants, antiretrovirals, immunosuppressants and antineoplastics. CMS
has also mandated that PDPs must cover an emergency supply of non-covered
medications during the appeals process in the long-term care setting. The
logistics for this process are determined by each PDP, which could vary
considerably among PDPs.
Does PharMerica meet pharmacy standards required by CMS to
operate with PDPs in the Medicare Part D environment?
PharMerica is uniquely positioned to assist PDPs by exceeding the minimum
standards for network long-term care pharmacies set by CMS, due to our
extensive clinical and operational expertise.
Do long-term care facilities contract with PDPs?
No. Only eligible long-term care pharmacy providers, like PharMerica, will
directly contract with PDPs. Facilities have no contractual relationship with
PDPs. If you receive any documents from PDPs requesting action on your part,
including signatures, please let us know, as we will work with you ensure these
requests are reviewed and processed appropriately. Facilities may, however,
contract with MA-PDs, which is similar to contracting with managed care
organizations, as you have done in the past.
How will PharMerica assist facilities in working with PDPs?
PharMerica has partnered with our customers to evaluate PDPs to help facilities
operationalize Medicare Part D with the least amount of confusion. We educate
customer facilities on PDPs and their effect for the education
of residents, families and responsible parties. Additionally, we will
provide physicians with assistance in the non-covered drug appeals process, and
work with PDPs and facilities to establish an effective transition process for
MMA-excluded and non-formulary drugs.
What does CMS do to communicate with dual eligible
beneficiaries about eligibility and PDPs?
Each Fall, CMS sends notices to dual-eligibles, reminding them of
their status. Duals are also being informed of the open enrollment
period, which occurs between November 15 and December 31. Because their monthly
premiums are subsidized by the government, dual-eligibles are pre-assigned into
plans that have the lowest monthly premium costs. If dual-eligibles decide to
change to a plan that may be more appropriate to meet their health needs, these
beneficiaries should seek to enroll in a PDP that maintains the lowest monthly
premium cost in order to ensure their prescription costs are appropriately
covered by the government. If they do not enroll into a different PDP during
open enrollment, they will be auto-enrolled into the randomly assigned PDP.
However, institutionalized dual-eligibles have the right to change PDPs at any
time during the enrollment period, and once per month beyond the enrollment
period.
Do dual-eligible beneficiaries in long-term care facilities
have to pay anything for prescription medications under Medicare Part D?
Generally, no. Dual-eligible residents of long-term care facilities will not
have to pay for prescription medications under Medicare Part D in most cases.
These beneficiaries do not have to pay monthly premiums, as long as they enroll
into plans at the CMS-designated baseline regional premium amount. This is an
amount set by CMS in each PDP region which indicates what price the government
will pay for premiums (through subsidies). Dual-eligibles who choose a PDP with
a premium that exceeds this baseline amount for the local region may experience
variance billing, which results in a monthly fee charged to the resident that
the government does not cover.
How does PharMerica educate customers about Medicare Part D?
We educate our customers on the latest developments through a variety of
formats, including teleconferences, webcasts, reading material and speaker
programs. Look for additional materials to be developed on a continuing basis,
including educational materials for families, residents and physicians.
Is Medicare Part D information currently available for
residents and responsible parties?
Yes. If you would like to convey information to residents and responsible
parties about the Medicare Part D prescription drug benefit, feel free to visit
the following websites often to receive the latest information:
PharMerica
http://www.pharmerica.com
Offers a variety of resources including frequently asked questions, information
about the final regulations, webcast access, links to other sites and the
ability to request a complimentary Medicare Part D consultation.
The Centers for Medicare and Medicaid Services (CMS)
http://www.medicare.gov/medicarereform
Provides access to the most current information regarding the Medicare
Prescription Drug Improvement and Modernization Act of 2003 (MMA) to help
beneficiaries make the best decisions regarding Medicare coverage. Their site
also includes resources in non-English languages, allows visitors to download
or order the Medicare Outreach Toolkit about the drug benefit, hosts
interactive training modules through the national Medicare & You training
program and provides a useful tool for those interested in selecting a Medicare
Advantage Plan.
Social Security Administration
http://www.socialsecurity.gov
and
http://www.socialsecurity.gov/organizations/medicareoutreach2/
Provides information about the prescription drug benefit and how to apply for
the low income subsidy.
The U.S. Administration on Aging
http://www.benefitscheckup.org/rx
Helps people learn about and enroll in government benefits, including the new
prescription drug benefit and other valuable federal, state and private
programs that can save money on health care.
|
 |